id	domain	url
amwa-17	www.who.int	https://www.who.int/initiatives
amwa-17	www.who.int	https://www.who.int/initiatives/act-accelerator
amwa-17	www.who.int	https://www.who.int/news-room/fact-sheets/detail/middle-eastrespiratory-syndrome-coronavirus-(mers-cov
amwa-17	www.who.int	https://www.who.int
amwa-17	www.who.int	https://www.who.int/emergencies/disease-outbreak-news
amwa-17	www.who.int	https://www.who.int/emergencies
amwa-17	www.massbio.org	https://www.massbio.org/news/recent-news/the-impact-of-themassachusetts-life-sciences-supplyhub
amwa-17	www.who.int	https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirushttps://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov
amwa-17	www.who.int	https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_1
amwa-17	www.who.int	https://www.who.int/emergencies/disease-outbreak-news/item/2020-don229
amwa-17	www.who.int	https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#event-22
amwa-17	www.massbio.org	https://www.massbio.org/news/recent-news/the-impact-of-the-massachusetts-life-sciences-supplyhub
amwa-17	www.massbio.org	https://www.massbio.org/news/recent-news/the-impact-of-the-massachusetts-life-sciences-supplyhub
amwa-17	www.the-scientist.com	https://www.the-scientist.com/bio-business/how-the-pharmaindustry-pulled-off-the-pivot-to-covid-19-67719
amwa-17	www.who.int	https://www.who.int
amwa-17	www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov/nuccore/mn908947
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fdaannounces-key-actions-advance-development-novel-coronavirusmedical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fdaguidance-documents/emergency-use-authorization-medical-productsand-related-authorities
amwa-17	www.fda.gov	https://www.fda.gov/news-events/pressannouncements/fda-takes-significant-step-coronavirus-responseefforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/policy-coronavirusdisease-2019-tests-during-public-health-emergency-revised
amwa-17	www.fda.gov	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-takes-new-actionsaccelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/covid-19-public-health-emergency-general-considerationspre-ind-meeting-requests-covid-19-related
amwa-17	www.fda.gov	https://www.fda.gov
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/statistical-considerations-clinical-trials-during-covid-19public-health-emergency-guidance-industry
amwa-17	www.fda.gov	https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/development-andlicensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov
amwa-17	www.fda.gov	https://www.fda.gov/media/138946
amwa-17	www.who.int	www.who.int/emergencies/diseases/novel-coronavirus-2019/globalresearch-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-forcovid-19-treatments
amwa-17	www.clinicaltrials.gov	https://www.clinicaltrials.gov
amwa-17	www.biopharmadive.com	https://www.biopharmadive.com/news
amwa-17	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov
amwa-17	www.cancer.org	https://www.cancer.org/latest-news/common-questions-about-thenew-coronavirus-outbreak.html
amwa-17	www.fda.gov	https://www.fda.gov/news-events
amwa-17	www.transceleratebiopharmainc.com	https://www.transceleratebiopharmainc.com/covid-19
amwa-17	www.transceleratebiopharmainc.com	www.transceleratebiopharmainc.com/assets/clinical-content-reusesolutions
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/searchfda-guidance-documents/assessing-covid-19-related-symptomsoutpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	www.the-scientist.com	https://www.the-scientist.com/bio-business/how-the-pharma-industry-pulled-off-the-pivot-to-covid-19-67719
amwa-17	www.the-scientist.com	https://www.the-scientist.com/bio-business/how-the-pharma-industry-pulled-off-the-pivot-to-covid-19-67719
amwa-17	www.who.int	https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
amwa-17	www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov/nuccore/mn908947
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures
amwa-17	www.fda.gov	https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-related
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-related
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-related
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-related
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-developing-drugs-and-biological-products-treatment-or-prevention
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/media/142749/download
amwa-17	www.fda.gov	https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine
amwa-17	www.fda.gov	https://www.fda.gov/media/138946/download
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
amwa-17	www.clinicaltrials.gov	https://www.clinicaltrials.gov
amwa-17	www.biopharmadive.com	https://www.biopharmadive.com/news/coronavirus-clinical-trial-disruption-biotech-pharma/574609
amwa-17	www.europeanpharmaceuticalreview.com	https://www.europeanpharmaceuticalreview.com/news/128134/impact-of-covid-19-on-clinical-trials-continuing-say-researchers
amwa-17	www.cdc.gov	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
amwa-17	www.cancer.org	https://www.cancer.org/latest-news/common-questions-about-the-new-coronavirus-outbreak.html
amwa-17	www.cancer.org	https://www.cancer.org/latest-news/common-questions-about-the-new-coronavirus-outbreak.html
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-guidance-conducting-clinical-trials
amwa-17	www.transceleratebiopharmainc.com	https://www.transceleratebiopharmainc.com/covid-19
amwa-17	www.transceleratebiopharmainc.com	https://www.transceleratebiopharmainc.com/assets/clinical-content-reuse-solutions/36
amwa-17	www.transceleratebiopharmainc.com	https://www.transceleratebiopharmainc.com/assets/clinical-content-reuse-solutions/36
amwa-17	www.transceleratebiopharmainc.com	https://www.transceleratebiopharmainc.com/assets/clinical-content-reuse-solutions/36
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	www.fda.gov	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs
amwa-17	stacks.cdc.gov	https://stacks.cdc.gov
amwa-17	www.who.int	https://www.who.int/news/item/0312-2020-global-access-to-covid-19-vaccines-estimated-to-generateeconomic-benefits-of-at-least-153-billion-in-2020-21
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-firstemergency-use-validation-for-a-covid-19-vaccine-and-emphasizesneed-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/teams
amwa-17	www.who.int	https://www.who.int
amwa-17	health.mo.gov	https://health.mo.gov/living/healthcondiseases
amwa-17	www.nih.gov	https://www.nih.gov/news-events
amwa-17	www.nih.gov	https://www.nih.gov/news-events
amwa-17	www.fda.gov	https://www.fda.gov/drugs/coronavirus-covid-19drugs/coronavirus-treatment-acceleration-program-ctap
amwa-17	www.fda.gov	https://www.fda.gov/emergency-preparedness-and-response
amwa-17	www.fda.gov	https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-firstdiagnostic-test-screening-people-without-known-or
amwa-17	www.amwa.org	www.amwa.org/fit
amwa-17	stacks.cdc.gov	https://stacks.cdc.gov/view/cdc/99303
amwa-17	www.who.int	https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21
amwa-17	www.who.int	https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21
amwa-17	www.who.int	https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
amwa-17	www.who.int	https://www.who.int/teams/blueprint/covid-19
amwa-17	www.who.int	https://www.who.int/publications/m/item/a-coordinated-global-research-roadmap
amwa-17	www.who.int	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations
amwa-17	health.mo.gov	https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus-lpha/pdf/fact-sheet-operation-warp-speed.pdf
amwa-17	www.nih.gov	https://www.nih.gov/news-events/news-releases/nih-launch-public-private-partnership-speed-covid-19-vaccine-treatment-options
amwa-17	www.nih.gov	https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools
amwa-17	www.fda.gov	https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap
amwa-17	www.fda.gov	https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap
amwa-17	www.fda.gov	https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19
amwa-17	www.fda.gov	https://www.fda.gov/media/141312/download
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or
amwa-17	www.fda.gov	https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or
amwa-17	www.amwa.org	http://www.amwa.org/fit